ALBANY, N.Y., Aug. 08, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer, President and Chief Executive Officer, is scheduled to present at the 2016 Canaccord Genuity Growth Conference on Wednesday, August 10, 2016, at 4:30 p.m. ET. The conference will be held at the InterContinental in Boston, Mass.
A live audio and/or webcast and subsequent archived replay of AngioDynamics' presentation may be accessed via the investor relations section of the Company's website under "Events & Presentations" at http://investors.angiodynamics.com/events.cfm. The replay will be available for 90 days after the event.
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access,
surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.
AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate
or a subsidiary.
AngioDynamics Inc.Caitlin Stefanik
Investor Relations Contacts:
News Provided by Acquire Media